All HEI'sATU DonegalATU Galway-MayoATU SligoDublin City UniversityDun Laoghaire IADTDundalk ITMaynooth UniversityMTU CorkMTU KerryNational College of Ireland (NCI)NCADRoyal College of SurgeonsSETU CarlowSETU WaterfordTeagascTrinity College DublinTUD BlanchardstownTUD GrangegormonTUD TallaghtTUS AthloneTUS LimerickUniversity College CorkUniversity College DublinUniversity of GalwayUniversity of Limerick All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsModifying Macrophages for the Treatment of Inflammatory DiseasesMacrophages are a sub-type of immune cells that are critical for fighting infection in the body through the release of inflammatory and toxic mediators. However if inflammation persists these Macrophages become destructi... pdf 306.3KBProtein Biomarkers for the Prediction of Psychosis.A blood-based biomarker test for predicting the transition to first episode psychosis in Clinical High Risk (CHR) patients. This blood-based biomarker test can be used alone or in conjunction with clinical data and has s... pdf 324.6KBTherapeutic Approach to Restore Haemostasis in Individuals with HaemophiliaA therapeutic approach for the treatment of haemophilia in individuals by restoring their levels of haemostasis through anticoagulant pathways mediated by Activated Protein C (APC).pdf 498KBTherapeutic Options for Obesity and Metabolic Syndrome The development of new therapies for the treatment of obesity attributable to genetic factors. Treatment strategies are available but the side effects associated with their use necessitates the development of new and no... pdf 388.6KBA Mimetic Peptide as a Treatment for Breast Cancer The global market for ER-positive breast cancer is estimated to be 2.86 billion. Despite availability of effective treatments, survival rates are low in Stage IV as compared to other stages. ADAM22 is a novel therapeutic... pdf 580KB First 123 Last Print Bookmark Top